PODCAST: THE BIO REPORT
John Hoekman, co-founder and CEO of Junevity, discusses the role of transcription factors in healthy biology and aging-related disease, the company’s AI-driven platform for identifying dysregulated transcription factors, and its lead programs targeting type 2 diabetes and obesity.
John Hoekman, PhD, Co-founder & CEO at Junevity
Listen here: https://thebioreport.podbean.com/e/hitting-the-reset-button-on-cellular-aging/